Amazon Removes Unapproved Eye Drops from Platform Following FDA Warning

Amazon is removing seven eyedrop products from its website after receiving a warning from the FDA stating that the products are not FDA-approved and pose a risk to public health. The FDA emphasized that eye products bypass natural defenses and can cause harm. The products included in the warning are Similasan Pink Eye Relief, The Goodbye Company Pink Eye, Can-C Eye Drops, Optique 1 Eye Drops, OcluMed Eye Drops, TRP Natural Eye Floaters Relief, and Manzanilla Sophia Chamomile Herbal Eye Drops. Amazon stated that safety is a top priority and that the products are being investigated and removed. This warning follows the FDA's recent urging for customers to stop using 26 over-the-counter eye drop products from various brands due to the risk of eye infections and vision loss.
- Amazon pulls several eyedrops after FDA warning The Hill
- Amazon to Stop Selling Seven Eyedrops After F.D.A. Warning The New York Times
- Amazon removes 7 eye-drop products after FDA warning The Washington Post
- FDA warns Amazon against sale of unapproved eye drops KSL.com
- Amazon says unapproved eye drops being removed from its platform Reuters
- View Full Coverage on Google News
Reading Insights
0
0
1 min
vs 2 min read
60%
318 → 128 words
Want the full story? Read the original article
Read on The Hill